Changes in Sensitivity to the Effects of Atrazine on the Luteinizing Hormone Surge in Female Sprague-Dawley Rats After Repeated Daily Doses: Correlation with Liver Enzyme Expression
Overview
Toxicology
Authors
Affiliations
Background: Atrazine suppression of the LH surge slowly develops over time and peaks after 4 days; sensitivity to atrazine decreases after 8 or 14 days of dosing. Adaptation of the LH response was correlated with increased phase I and phase II liver enzyme activity/expression.
Methods: The effect of atrazine on the LH surge was evaluated in female Sprague-Dawley rats administered 100 mg/kg/day atrazine by gavage for 1, 2, 3, or 4 consecutive days or 6.5, 50, or 100 mg/kg/day atrazine for 4, 8, or 14 days.
Results: No statistically significant effects of atrazine were seen on peak plasma LH or LH area under the curve (AUC) after one, two, or three doses of 100 mg/kg/day. Four daily doses of 50 or 100 mg/kg atrazine significantly reduced peak LH and LH AUCs, whereas 6.5 mg/kg/day had no effect. After 8 or 14 days of treatment, statistically significantly reduced peak LH and LH AUC were observed in the 100 mg/kg/day dose group, but not in the 6.5 or 50 mg/kg/day dose groups, although significantly reduced LH was observed in one sample 9 hr after lights-on in the 50 mg/kg/day dose group on day 14. The number of days of treatment required to achieve a significant suppression of the LH surge is consistent with the repeat-dose pharmacokinetics of the chlorotriazines.
Conclusion: The apparent adaptation to the effect of atrazine on the LH surge after 8 or 14 days may be related to the induction of phase I or, more likely, phase II metabolism observed in this study after 8 days, or to a decreased sensitivity of the hypothalamic-pituitary-adrenal axis or an homeostatic adaption of the effect of atrazine on the LH surge mechanism. Birth Defects Research 110:246-258, 2018. © 2017 The Authors. Birth Defects Research Published by Wiley Periodicals, Inc.
Lamnoi S, Boonupara T, Sumitsawan S, Vongruang P, Prapamontol T, Udomkun P Sci Rep. 2024; 14(1):13327.
PMID: 38858445 PMC: 11164915. DOI: 10.1038/s41598-024-64291-2.
Atrazine Toxicity: The Possible Role of Natural Products for Effective Treatment.
Das S, Sakr H, Al-Huseini I, Jetti R, Al-Qasmi S, Sugavasi R Plants (Basel). 2023; 12(12).
PMID: 37375903 PMC: 10301673. DOI: 10.3390/plants12122278.
Chloro-s-triazines-toxicokinetic, Toxicodynamic, Human Exposure, and Regulatory Considerations.
Abass K, Pelkonen O, Rautio A Curr Drug Metab. 2021; 22(8):645-656.
PMID: 34218777 PMC: 8811613. DOI: 10.2174/1389200222666210701164945.